MDS and AML are both cancers affecting hematopoietic stem cells in one or more cell lines, eventually leading to bone marrow failure if left untreated. The goal of this Recommendations Report is to review the most current evidence comparing treatment modalities that include an SCT component, and to make a series of clinical recommendations to inform clinicians, patients, and other stakeholders of the treatment options available.
Authors
Kouroukis, T, Schuh, A, Rumble, R. B, Walker, I, Bredeson, Christopher
- Pages
- 33
- Published in
- Ottawa, Ontario
